News you can use: health & drug safety updates

2015

  • August 13, 2015

    NCPIE’s Talk Before You Take campaign launched earlier this year. A recent article published in the Washington Post, “The Risky Business of Taking Antibiotics,” highlighted the story of a patient named Barbara Odanaka, who experienced fluoroquinolone toxicity after being prescribed an antibiotic called levofloxacin while she was hospitalized with severe pneumonia. Odanaka noted in the article that levofloxacin’s potential adverse effects were not properly explained to her. Pharmacy Today/Pharmacist.com

  • August 11, 2015
    As parents and caregivers fill out a multitude of forms at the start of the school year, they may have questions about some requirements, including the vaccine schedule. According to Marion Gruber, Ph.D., director of the Office of Vaccines Research and Review at the Food and Drug Administration (FDA), vaccines are integral to get children off to a healthy start. “Parents should know that vaccines protect children from many serious illnesses from infectious diseases. The risk of being harmed by vaccines is much smaller than the risk of serious illness from infectious diseases,” she says.
  • August 10, 2015
    Article by Dan Leonard, President of the National Pharmaceutical Council and Member NCPIE Board of Directors
  • August 5, 2015
    A guidance entitled “Over-the-Counter Pediatric Oral Liquid Drug Products Containing Acetaminophen” is being issued by FDA “to help drug manufacturers, packagers, and labelers minimize the risk to consumers of acetaminophen-related liver damage associated with the use of nonprescription pediatric oral liquid acetaminophen drug products,” according to a Federal Register notice to be published Aug. 5. This guidance provides recommendations regarding acetaminophen concentration, container labels, carton labeling and packaging of such
  • August 5, 2015
    Descargo de responsabilidad: La FDA reconoce la necesidad de proporcionar información importante sobre seguridad de los medicamentos en idiomas distintos al inglés. Hacemos lo mejor posible para proporcionar versiones en español precisas y oportunas de nuestras Comunicaciones de Seguridad de Medicamentos. Sin embargo, en caso que existiera discrepancias entre las versiones en inglés y la de español, la información contenida en la versión en inglés es la que se considera como versión oficial. Si tiene alguna pregunta, por favor contáctese
  • August 4, 2015
    Flu vaccine supplies are shipping soon for provider offices, hospitals, pharmacies. Influenza vaccine is recommended or required for all healthcare providers. Take the pledge and share the pledge widely to encourage family, caregivers, and all patients to receive their flu vaccine. Click here for the basics about flu.
  • August 4, 2015
    The AMA Task Force to Reduce Opioid Abuse announced the first of several recommendations for halting America’s opioid abuse epidemic. The initial focus will be on urging physicians to use state-based prescription drug monitoring programs when considering treatment options. The task force is made up of 27 physician organizations including the American Medical Association. The new initiative will seek to significantly enhance physicians' education on safe, effective and evidence-based prescribing. This includes a new resource web page that houses vital information on
  • August 1, 2015

    APhA Pharmacy Today

  • July 28, 2015
    Women face unique issues when it comes to substance use, both biological (sex) and cultural (gender). This new online resource by the National Institute on Drug Abuse (NIDA), provides information on the importance of scientific research into sex and gender issues related to drug use. It includes research summaries about women and commonly abused drugs, including marijuana and prescription medications. Additionally, this new web section summarizes the latest research related to drug use while pregnant or breastfeeding, along with what science has
  • July 24, 2015
    The FDA will examine how pharmaceutical manufacturers’ effectiveness claims in direct-to-consumer prescription drug advertising affect consumer beliefs about medication quality. In a two-part study, OPDP will survey patients with diabetes using nine different mock print ads with varying levels of efficacy information. Researchers will then test respondents to gauge their memory, perception and understanding of the drug risks and benefits.

Pages